How should vilazodone (a selective serotonin reuptake inhibitor) be discontinued after a dose of 10 mg over 2.5 weeks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Discontinuation Protocol for Vilazodone After 10 mg for 2.5 Weeks

Vilazodone should be tapered to 10 mg once daily for 7 days before discontinuation to minimize withdrawal symptoms. 1

Recommended Discontinuation Protocol

For a patient who has been taking vilazodone 10 mg for 2.5 weeks:

  • Since the patient is already at the lowest available dose (10 mg), continue this dose once daily for 7 days and then discontinue 1
  • Take medication with food during the tapering period to ensure adequate plasma concentrations 1
  • Monitor for discontinuation symptoms during and after the tapering period 1

Rationale for Tapering

  • Abrupt discontinuation of SSRIs like vilazodone can lead to discontinuation syndrome 2
  • The FDA-approved drug label specifically recommends gradual reduction rather than abrupt cessation to minimize adverse reactions upon discontinuation 1
  • Even at the lowest dose (10 mg), a 7-day tapering period is recommended before complete discontinuation 1

Potential Discontinuation Symptoms

Discontinuation syndrome may include:

  • Dizziness, fatigue, lethargy, general malaise 2
  • Myalgias, chills, headaches 2
  • Gastrointestinal symptoms (nausea, vomiting, diarrhea) 2
  • Sleep disturbances (insomnia) 2
  • Sensory disturbances, paresthesias 2
  • Psychological symptoms (anxiety, irritability, agitation) 2

Special Considerations

  • Even though the treatment duration has been relatively short (2.5 weeks), tapering is still recommended as discontinuation symptoms can occur even with brief treatment periods 1
  • If discontinuation symptoms emerge despite tapering, consider resuming the previous dose temporarily and then tapering more gradually 2
  • The risk of serotonin syndrome persists during the discontinuation period, so avoid starting any other serotonergic medications during this time 2

Clinical Monitoring During Discontinuation

  • Monitor for clinical worsening of depression and emergence of suicidal thoughts during the tapering period 1
  • Assess for signs of discontinuation syndrome at follow-up appointments 2
  • Educate the patient about potential discontinuation symptoms and when to seek medical attention 2

Common Pitfalls to Avoid

  • Avoid abrupt discontinuation even at the lowest dose of 10 mg, as this increases the risk of discontinuation syndrome 1
  • Do not start another serotonergic medication immediately after discontinuation without an appropriate washout period (at least 14 days after stopping vilazodone) 1
  • Do not overlook the importance of taking vilazodone with food during the tapering period, as inadequate plasma concentrations may exacerbate discontinuation symptoms 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.